top of page

Digital Endpoint Value Reimbursement for New Drugs Developed using Digital Drug Development tools

DiMe and our partners on the 3Ps of Digital Endpoint Value project have developed a toolkit of resources to support those developing and deploying digital endpoints as value evidence in reimbursement decisions. By implementing these resources now, our field will be ready for success when the first digital endpoints are accepted in support of new drug approvals.

3Ps of Digital Endpoint Value – Digital Medicine Society (DiMe) (

bottom of page